Company Overview of Ivrea Pharmaceuticals, Inc.
Ivrea Pharmaceuticals, Inc., a specialty pharmaceutical company, provides clinical development and commercialization of prescription pharmaceuticals for the treatment of dermatologic conditions, such as onychomychosis, acne, and photodamage. Its products include IVR 101/102 which combines gels with known fungicidal active ingredients, thus creating dermatological prescription products for the treatment of onychomycosis; and IVR 103 which utilizes proprietary platform technology to reduce the level of irritation associated with all trans retinoic acid (also called tretinoin) while treating acne. The company was founded in 2005 and is based in Quincy, Massachusetts.
216 Ricciuti Drive
Quincy, MA 02169
Founded in 2005
Key Executives for Ivrea Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Astarix Institute||United States|
|NeilMed Pharmaceuticals, Inc.||United States|
|SOV Therapeutics, Inc.||United States|
|Critical Care Systems International, Inc.||United States|
|Palingen, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ivrea Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.